Several Alliance medical specialty societies wrote to CMS Administrator Tavenner to express concerns with the proposed rule that would modify aspects of the Medicare Advantage and
Part D prescription drug program to the detriment of beneficiaries.
Several Alliance medical specialty societies wrote to CMS Administrator Tavenner to express concerns with the proposed rule that would modify aspects of the Medicare Advantage and
Part D prescription drug program to the detriment of beneficiaries.
Specialty Docs Provide Feedback on Medicare Provider Enrollment Proposals August 21, 2026
Alliance Supports Legislation to Modernize the Medicare Physician Fee Schedule August 7, 2026
Alliance Voices Strong Concerns over OMB Federal Financial Assistance Rule July 13, 2026
Alliance Comments on Rule to Streamline Prior Authorization for Drugs and Improve Data Exchange June 15, 2026© 2026 Alliance of Specialty Medicine. All rights reserved. Website designed and developed by Orpheus, Inc..

